An Overview of Vanadium and Cell Signaling in Potential Cancer Treatments

被引:31
作者
Alejandra Ferretti, Valeria [1 ]
Esteban Leon, Ignacio [1 ,2 ]
机构
[1] Univ Nacl La Plata, Dept Quim, Asociado CIC, Cequinor UNLP,Fac Ciencias Exactas,CCT CONICET La, Blvd 120 1465, RA-1900 La Plata, Buenos Aires, Argentina
[2] Univ Nacl La Plata, Dept Ciencias Biol, Catedra Fisiopatol, Fac Ciencias Exactas, RA-1900 La Plata, Buenos Aires, Argentina
关键词
vanadium biochemistry; cell signaling; cancer; anticancer agents; FOCAL ADHESION KINASE; IN-VITRO; ANTICANCER ACTIVITY; OXIDOVANADIUM(IV) COMPLEXES; FLAVONOID CHRYSIN; VO-CLIOQUINOL; ACTIVATION; INHIBITION; SODIUM; TARGET;
D O I
10.3390/inorganics10040047
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Vanadium is an ultratrace element present in higher plants, animals, algae, and bacteria. In recent years, vanadium complexes have been studied to be considered as a representative of a new class of nonplatinum metal anticancer drugs. Nevertheless, the study of cell signaling pathways related to vanadium compounds has scarcely been reported on and reviewed thus far; this information is highly critical for identifying novel targets that play a key role in the anticancer activity of these compounds. Here, we perform a review of the activity of vanadium compounds over cell signaling pathways on cancer cells and of the underlying mechanisms, thereby providing insight into the role of these proteins as potential new molecular targets of vanadium complexes.
引用
收藏
页数:11
相关论文
共 59 条
[1]   The state-of-play and future of platinum drugs [J].
Apps, Michael G. ;
Choi, Eugene H. Y. ;
Wheate, Nial J. .
ENDOCRINE-RELATED CANCER, 2015, 22 (04) :R219-R233
[2]   In silico and in vitro analysis of FAK/MMP signaling axis inhibition by VO-clioquinol in 2D and 3D human osteosarcoma cancer cells [J].
Balsa, Lucia M. ;
Quispe, Patricia ;
Baran, Enrique J. ;
Lavecchia, Martin J. ;
Leon, Ignacio E. .
METALLOMICS, 2020, 12 (12) :1931-1940
[3]   Vanadium and bone development: putative signaling pathways [J].
Barrio, D. A. ;
Etcheverry, S. B. .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2006, 84 (07) :677-686
[4]   Exploration of the medical periodic table: towards new targets [J].
Barry, Nicolas P. E. ;
Sadler, Peter J. .
CHEMICAL COMMUNICATIONS, 2013, 49 (45) :5106-5131
[5]   Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway [J].
Basu, Abhishek ;
Roy, Somnath Singha ;
Bhattacharjee, Arin ;
Bhuniya, Avishek ;
Baral, Rathindranath ;
Biswas, Jaydip ;
Bhattacharya, Sudin .
FREE RADICAL RESEARCH, 2016, 50 (01) :39-55
[6]   Vanadyl ions stimulate K+ uptake into isolated perfused rat liver via the Na+/K+-pump by a tyrosine kinase-dependent mechanism [J].
Bruck, R ;
Halpern, Z ;
Aeed, H ;
Shechter, Y ;
Karlish, SJD .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1998, 435 (05) :610-616
[7]   Targeted delivery of platinum-based anticancer complexes [J].
Butler, Jennifer S. ;
Sadler, Peter J. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2013, 17 (02) :175-188
[8]   Analysis of phosphorylation sites on focal adhesion kinase using nanospray liquid chromatography/multiple reaction monitoring mass spectrometry [J].
Ciccimaro, Eugene ;
Hevko, John ;
Blair, Ian A. .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (24) :3681-3692
[9]   VANADIUM DERIVATIVES ACT AS GROWTH-FACTOR - MIMETIC COMPOUNDS UPON DIFFERENTIATION AND PROLIFERATION OF OSTEOBLAST-LIKE UMR106 CELLS [J].
CORTIZO, AM ;
ETCHEVERRY, SB .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 145 (02) :97-102
[10]   The PI3K Pathway As Drug Target in Human Cancer [J].
Courtney, Kevin D. ;
Corcoran, Ryan B. ;
Engelman, Jeffrey A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :1075-1083